Preoperative endoscopic drainage for malignant obstructive jaundice.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 7741850)

Published in Br J Surg on August 01, 1994

Authors

E C Lai1, F P Mok, S T Fan, C M Lo, K M Chu, C L Liu, J Wong

Author Affiliations

1: Department of Surgery, University of Hong Kong, Queen Mary Hospital.

Articles citing this

Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65

Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87

A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg (2002) 1.79

Pancreatic adenocarcinoma. J Natl Compr Canc Netw (2010) 1.52

Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut (2005) 1.46

Current surgical treatment for bile duct cancer. World J Gastroenterol (2007) 1.30

Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut (2000) 1.28

Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol (2005) 1.17

Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) (2009) 1.06

Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev (2012) 1.03

Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg (2009) 1.01

Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford) (2008) 0.94

Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci (2010) 0.93

Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92

Ampullary carcinoma: effect of preoperative biliary drainage on surgical outcome. World J Gastroenterol (2009) 0.91

Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study. Gut (2002) 0.89

Effect of preoperative biliary drainage on malignant obstructive jaundice: a meta-analysis. World J Gastroenterol (2011) 0.89

Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg (2007) 0.89

Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88

Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol (2015) 0.84

Operable malignant jaundice: To stent or not to stent before the operation? World J Gastrointest Endosc (2010) 0.84

Immunomodulation in surgical practice. HPB (Oxford) (2006) 0.83

Current trends in preoperative biliary stenting in patients with pancreatic cancer. Surgery (2013) 0.83

Cost-effectiveness of preoperative biliary drainage for obstructive jaundice in pancreatic and periampullary cancer. J Surg Res (2014) 0.81

Fast-track management of patients undergoing proximal pancreatic resection. Ann R Coll Surg Engl (2009) 0.81

Diagnosis and management of pancreatic cancer. Minerva Gastroenterol Dietol (2009) 0.81

Pancreaticoduodenectomy for periampullary malignancies: the effect of bile colonization on the postoperative outcome. Langenbecks Arch Surg (2006) 0.81

Comparison of clinical outcome and cost-effectiveness after various preoperative biliary drainage methods in periampullary cancer with obstructive jaundice. J Korean Med Sci (2012) 0.81

Obstructive jaundice causes reduced expression of polymorphonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro. Gut (1996) 0.81

Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy--implications for timing of resectional surgery and use of biliary drainage. HPB (Oxford) (2006) 0.81

The current standard of care in the periprocedural management of the patient with obstructive jaundice. Ann R Coll Surg Engl (2006) 0.80

Effect of Preoperative Biliary Drainage on Complications Following Pancreatoduodenectomy: A Meta-Analysis. Medicine (Baltimore) (2015) 0.79

Percutaneous transhepatic insertion of self-expanding short metal stents for biliary obstruction before resection of pancreatic or duodenal malignancy proves to be safe and effective. Surg Endosc (2009) 0.78

Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction. Gut (1998) 0.78

Multicenter study of endoscopic preoperative biliary drainage for malignant distal biliary obstruction. World J Gastroenterol (2016) 0.78

The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg (2015) 0.78

The case against preoperative biliary drainage with pancreatic resection. HPB (Oxford) (2006) 0.77

An Update to Hepatobiliary Stents. J Clin Transl Hepatol (2015) 0.77

Endoscopic palliation of pancreatic cancer. Cancer J (2012) 0.77

Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol (2016) 0.75

A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy. HPB (Oxford) (2016) 0.75

Preoperative biliary drainage (stenting) for treatment of obstructive jaundice. HPB (Oxford) (2006) 0.75

Endoscopic palliation of malignant biliary strictures. World J Gastrointest Oncol (2016) 0.75

Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1995) 0.75

A case of methicillin-resistant Staphylococcus aureus infection following bile duct stenting. World J Gastroenterol (2005) 0.75

Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg (2016) 0.75

Current status of preoperative biliary drainage. J Gastroenterol (2015) 0.75

Articles by these authors

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32

Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66

NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58

Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med (1993) 5.84

Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (2001) 5.25

Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J (2000) 5.22

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97

A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44

Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29

Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol (2001) 4.08

Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23

A prospective study on fish bone ingestion. Experience of 358 patients. Ann Surg (1990) 3.19

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05

Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04

Francisella tularensis strain typing using multiple-locus, variable-number tandem repeat analysis. J Clin Microbiol (2001) 2.99

Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94

A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93

Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83

Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73

Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res (2001) 2.55

Compliance with postoperative instructions: a telephone survey of 750 day surgery patients. Anaesthesia (2001) 2.53

Mismatch repair co-opted by hypermutation. Science (1998) 2.49

Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47

Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44

Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37

alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol (2000) 2.36

A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20

HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene (2007) 2.19

Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17

Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15

Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A (2000) 2.13

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg (1997) 2.09

Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther (2014) 2.06

Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03

Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California. J Clin Microbiol (1993) 2.03

The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02

Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01

Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med (1979) 2.01

A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg (1982) 2.00

Two cases of acrometastasis to the hands and review of the literature. Curr Oncol (2008) 2.00

The Shatin community mental health survey in Hong Kong. II. Major findings. Arch Gen Psychiatry (1993) 1.99

Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98

Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg (1996) 1.97

Analysis of reduced death and complication rates after esophageal resection. Ann Surg (2001) 1.96

Adaptive radiation therapy. Phys Med Biol (1997) 1.94

Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med (1994) 1.93

Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93